Skip to main content
August 15, 2022

GDPR Scrutiny & Big Data

Insights: Life Sciences

Alexander Roussanov discusses recent developments that make it difficult and complex for medical device and pharmaceutical companies to navigate the General Data Protection Regulation (GDPR) in Europe. Regulators are scrutinizing every aspect of the data processing activities of life sciences companies, including the collection and use of clinical research data, advanced diagnostics, wearables and more.

This is the latest in our series: “Insights: Life Sciences” where we examine the legal issues and trends impacting the life sciences and healthcare industries.

» See the rest of the “Insights: Life Sciences” series here.

© Arnold & Porter Kaye Scholer LLP 2023 All Rights Reserved. This video is intended to be a general summary of the law and does not constitute legal advice. You should consult with counsel to determine applicable legal requirements in a specific fact situation.